Clinical Trials Directory

Trials / Unknown

UnknownNCT02984969

Using 16S rRNA Gene Sequencing Analysis Intestinal Microbiota in Constipation Patients

Characterization of Intestinal Microbiota in Constipation Patients: Using 16S rRNA Gene Sequencing Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Constipation is a frequent, chronic gastroenterological problem that has many varied symptoms and thus has several clinical definitions. According to the Rome III criteria for chronic constipation, almost 16% of all adults are affected by chronic constipation worldwide, and it is more prevalent and symptomatic in women and elderly people. Slow transit constipation (STC) is the major category and is characterized by a decreased rate of colonic transit. Recently, many researchers have focused on the relationship between intestinal microbiota and constipation and have demonstrated that intestinal microbiota contribute to the pathophysiology of functional gastrointestinal disorders. Thus, there is a need for an improved understanding of gut microbiota composition in constipation patients and for the potential role played by the gut microbiota in the etiology of STC.To achieve this goal the investigators characterized and compared the intestinal microbiota among carefully selected patients with constipation that were clinically categorized based on Rome III criteria, and healthy controls using high throughput pyrosequencing of the 16S rRNA gene and a conservative approach to detect quantitative changes in the relative abundances of taxa.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2016-11-01
Completion
2017-02-01
First posted
2016-12-07
Last updated
2016-12-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02984969. Inclusion in this directory is not an endorsement.